Introduction - Your latest trial sponsor is using AI to accelerate protocol development and patient recruitment,[1] cutting ...

In this Q&A, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, discusses how clinical ...

Summary: With the evolution of AI capabilities and adoption outpacing procedural frameworks, its important to reevaluate your approach to ESI protocols. Learn about four key considerations that will ...

In today's ACT Brief, we explore how diversity is embedded across trial planning at Merck, integration of patient-reported ...

In a world where giants of the conventional financial system including Visa, Mastercard and PayPal employ tens of thousands of employees, Bitcoin continues to be run by a tight ship of just a few ...

Analysis of the incidence of severe adverse events in Japanese cancer patients receiving outpatient chemotherapy. Cost differences among treatment options for patients with refractory myeloma ...